Figure 2.
Outcomes of patients completing autologous stem-cell transplantation. (A) Freedom from second failure (FF2F) and (B) overall survival (OS) of patients with first-relapsed or primary refractory Hodgkin lymphoma according to risk group. (C) FF2F and (D) OS of patients with primary refractory or unfavorable relapse.